Semaglutidea glucagon-like peptide-1 (GLP-1) receptor agonisthas demonstrated an average weight loss of 15-17% over 68 weeks in clinical trials, regardless of whether the medication comes from a brand-name manufacturer or a licensed compounding pharmacy
PlexusDx offers semaglutide, tirzepatide, oral and injectable options, and combination products, allowing your clinician to find the best fit for your side effect profile
While you're dealing with pain from an inflamed bicep tendon, fill an ice pack with ice and hold it against the area that's hurting for up to 20 minutes
A 2025 systematic review of 80 randomized clinical trials of patients taking GLP-1 RAs, published in the Journal of the American Medical Associations JAMA Psychiatry, found that GLP-1 RA treatment in patients with obesity and/or diabetes was not associated with an increased risk of depressive symptoms
503A vs 503B-What You Need to Know Now that weve covered the basics, lets take a look at what 503B means and what sets 503B outsourcing facilities apart
Engrafted glial progenitor cells yield long-term integration and sensory improvement in aged mice